WEST PHARMACEUTICAL SERVICES INC
About WEST PHARMACEUTICAL SERVICES INC
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $3.1B
- Net income
- $493.7M
- Total assets
- $4.3B
- Market cap
- $22.2B
- Gross margin
- 35.9%
- Operating margin
- 19.0%
- Net margin
- 16.1%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $3.1B
- Cost of revenue
- $2.0B
- Gross profit
- $1.1B
- Operating expenses
- $519.1M
- Operating income
- $584.9M
- Income tax
- $121.6M
- Net income
- $493.7M
- EPS (basic)
- $6.83
- EPS (diluted)
- $6.79
Balance sheet
- Total assets
- $4.3B
- Current assets
- $2.0B
- Total liabilities
- $1.1B
- Current liabilities
- $654.9M
- Shareholders’ equity
- $3.2B
Cash flow
- Operating cash flow
- $754.8M
- Investing cash flow
- -$285.9M
- Financing cash flow
- -$185.1M
- Net cash flow
- $306.7M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $22.2B
- P/E ratio
- 48.7
- EPS (diluted)
- $6.79
- Dividend yield
- 0.27%
- Shares outstanding
- 67.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 2, 1973
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $493.7M in FY2025.
- Revenue grew 9% from FY2021 to FY2025.
- Gross margin of 35.9%, net margin 16.1%.
- Trading near its 52-week high.
- Pays a dividend yielding about 0.27% annually.
- Valued at a price-to-earnings (P/E) ratio of 48.7.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review WEST PHARMACEUTICAL SERVICES INC.
Write a review
News about WEST PHARMACEUTICAL SERVICES INC
News & sentiment via Polygon.io
